Dataset Information
Lactobacillus rhamnosus GG (LGG) exhibits inhibitory effects against non-small cell lung cancer (NSCLC) and alleviates the adverse effects associated with gefitinib_Fecal metabolomics study in mice
Ontology highlight
ABSTRACT: After screening the bacteria both in vivo and in vitro, it was found that a certain candidate strain could significantly inhibit non-small cell lung cancer when combined with the drug gefitinib and alleviate the side effects of gefitinib. Next, the mechanism will be explored through in vivo and in vitro experiments.
INSTRUMENT(S): Liquid Chromatography MS - negative - reverse-phase, Liquid Chromatography MS - positive - reverse-phase
PROVIDER: MTBLS13811 | MetaboLights | 2026-09-03
REPOSITORIES: MetaboLights
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| HF3_CN1_FZTM240323059-1A.raw | Raw | |||
| HF3_CN1_FZTM240323060-1A.raw | Raw | |||
| HF3_CN1_FZTM240323061-1A.raw | Raw | |||
| HF3_CN2_FZTM240323068-1A.raw | Raw | |||
| HF3_CN2_FZTM240323070-1A.raw | Raw |
Items per page: 1 - 5 of 36 |